|
|
||||||||
From the Departments of Medicine and Genetics, Stanford University School of Medicine, Stanford, California 94305
Abstract
A highly specific anti-T cell antiserum (ATCS) was developed by extensively absorbing a goat anti-human thymocyte antiserum with human red cells and buffy coat cells from a patient with chronic lymphocytic leukemia. The ATCS was used in an in vitro cytotoxicity assay for detecting human thymus-derived (T) peripheral blood lymphocytes. A fluorescent cell sorter provided separated populations of normal immunoglobulin (Ig)-bearing and non-Ig-bearing lymphocytes on which to directly test the sensitivity and specificity of the ATCS. The antiserum killed almost 100% of non-Ig-bearing lymphocytes but less than 10% of Ig-bearing (B) lymphocytes and monocytes. Moreover, ATCS was able to abrogate the response to phytohemagglutinin stimulation, a T cell response.
In further studies, Ficoll-purified peripheral blood cells from 12 normal donors were examined for the per cent Ig-bearing cells, monocytes and cells killed by ATCS. A mean of 21% of these cells were B lymphocytes, 17% were monocytes, and 65% were T lymphocytes, thus accounting for 100% of the cells.
Footnotes
1 This work was supported by United States Public Health Service Grants AI 10293, AI 11313, and GM 17367.
2 Recipient of Special Fellowship GM 53244 from the National Institute of General Medical Sciences.
3 Recipient of Career Development Award AI 70018 from the National Institute for Allergy and Infectious Diseases.
This article has been cited by other articles:
![]() |
P. Horan and L. Wheeless Jr Quantitative single cell analysis and sorting Science, October 14, 1977; 198(4313): 149 - 157. [PDF] |
||||
![]() |
S Slavin, S Strober, Z Fuks, and H. Kaplan Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation Science, September 24, 1976; 193(4259): 1252 - 1254. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |